Angelo Demarzo

NPI: 1770510380
Total Payments
$48,790
2022 Payments
$1,908
Companies
5
Transactions
15
Medicare Patients
205
Medicare Billing
$17,887

Payment Breakdown by Category

Consulting$48,183 (98.8%)
Food & Beverage$355.55 (0.7%)
Travel$251.46 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $48,183 7 98.8%
Food and Beverage $355.55 3 0.7%
Travel and Lodging $251.46 5 0.5%

Top Paying Companies

Company Total Records Latest Year
Cepheid $45,000 5 $0 (2020)
Merck Sharp & Dohme LLC $3,183 2 $0 (2022)
GENZYME CORPORATION $301.53 3 $0 (2018)
SANOFI-AVENTIS U.S. LLC $294.17 4 $0 (2017)
Roche Diagnostics Corporation $11.31 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2022 $1,908 1 Merck Sharp & Dohme LLC ($1,908)
2021 $1,275 1 Merck Sharp & Dohme Corporation ($1,275)
2020 $7,500 1 Cepheid ($7,500)
2019 $15,000 2 Cepheid ($15,000)
2018 $22,813 6 Cepheid ($22,500)
2017 $294.17 4 SANOFI-AVENTIS U.S. LLC ($294.17)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/28/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $1,907.50 General
07/07/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,275.00 General
07/10/2020 Cepheid GENEXPERT (Device) Consulting Fee Cash or cash equivalent $7,500.00 General
Category: MOLECULAR DIAGNOSTICS
11/20/2019 Cepheid Consulting Fee Cash or cash equivalent $7,500.00 General
05/10/2019 Cepheid Consulting Fee Cash or cash equivalent $7,500.00 General
10/26/2018 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Food and Beverage In-kind items and services $207.35 General
10/26/2018 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Travel and Lodging Cash or cash equivalent $88.61 General
10/26/2018 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Travel and Lodging Cash or cash equivalent $5.57 General
08/15/2018 Roche Diagnostics Corporation TD VENTANA Digital Pathology Products (Device) Food and Beverage In-kind items and services $11.31 General
Category: Tissue Diagnostics
08/09/2018 Cepheid GENEXPERT (Device) Consulting Fee Cash or cash equivalent $7,500.00 General
Category: MOLECULAR DIAGNOSTICS
01/05/2018 Cepheid GENEXPERT (Device) Consulting Fee Cash or cash equivalent $15,000.00 General
Category: MOLECULAR DIAGNOSTICS
10/07/2017 SANOFI-AVENTIS U.S. LLC NO PRODUCT DISCUSSED (Drug) Food and Beverage In-kind items and services $136.89 General
10/07/2017 SANOFI-AVENTIS U.S. LLC NO PRODUCT DISCUSSED (Drug) Travel and Lodging Cash or cash equivalent $14.72 General
10/06/2017 SANOFI-AVENTIS U.S. LLC NO PRODUCT DISCUSSED (Drug) Travel and Lodging In-kind items and services $71.28 General
10/05/2017 SANOFI-AVENTIS U.S. LLC NO PRODUCT DISCUSSED (Drug) Travel and Lodging In-kind items and services $71.28 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 111 164 $37,020 $8,977
2022 3 58 77 $21,514 $5,475
2021 2 23 35 $11,198 $2,885
2020 1 13 17 $2,845 $549.62
Total Patients
205
Total Services
293
Medicare Billing
$17,887
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88309 Pathology examination of tissue using a microscope, high complexity Facility 2023 29 29 $13,057 $3,468 26.6%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2023 23 45 $12,375 $3,067 24.8%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 33 37 $6,359 $1,136 17.9%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2023 13 40 $3,410 $933.59 27.4%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 13 13 $1,819 $373.23 20.5%
88309 Pathology examination of tissue using a microscope, high complexity Facility 2022 21 21 $8,778 $2,538 28.9%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2022 16 31 $8,525 $2,153 25.3%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 21 25 $4,211 $783.96 18.6%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2021 12 24 $6,600 $1,587 24.1%
88309 Pathology examination of tissue using a microscope, high complexity Facility 2021 11 11 $4,598 $1,297 28.2%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 13 17 $2,845 $549.62 19.3%

About Angelo Demarzo

Angelo Demarzo is a Anatomic Pathology & Clinical Pathology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770510380.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angelo Demarzo has received a total of $48,790 in payments from pharmaceutical and medical device companies, with $1,908 received in 2022. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($48,183).

As a Medicare-enrolled provider, Demarzo has provided services to 205 Medicare beneficiaries, totaling 293 services with total Medicare billing of $17,887. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

Products in Payments

  • GENEXPERT (Device) $30,000
  • NO PRODUCT DISCUSSED (Drug) $595.70
  • TD VENTANA Digital Pathology Products (Device) $11.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Baltimore